ARCHIVES

Plan To Reprogram $10 Million On Construction Funds Draws Criticism

This article is from The Cancer Letter archive.

Vol. 02 No. 47 | November 19, 1976

Download PDF Visit The Full Archive

Related Articles

In Phase II Study, NKTR-102 Shows Objective Response

January 28, 2011

Rosenberg Begins Trial To Immunize Patient against Tumor

October 11, 1991

Rituximab Maintenance Improves Survival In Relapse

February 27, 2009

BSA, BSC Approve Concept for NCI Scholars Program

March 7, 1997

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

June 2, 2006

In Brief: Panel To Meet In Chicago Dec. 15; Rosenberg Picks Up Another Famous Patient; Obey Honored

October 17, 1986